RHYTHM PHARMACEUTICALS, INC. Other Accrued Liabilities, Current
RHYTHM PHARMACEUTICALS, INC. (RYTM) had Other Accrued Liabilities, Current of $7.31 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Payables and Accruals › Accrued Liabilities, Current
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2026-08-04
- 2026-06-30: Other Accrued Liabilities, Current $7.31M.
- 2026-03-31: Other Accrued Liabilities, Current $5.14M.
- 2025-12-31: Other Accrued Liabilities, Current $4.08M.
- 2025-09-30: Other Accrued Liabilities, Current $3.40M.
| Period end | Other Accrued Liabilities, Current | Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $7.31M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $5.14M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $4.08M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $3.40M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $4.38M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $5.80M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $4.35M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $4.31M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $5.78M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $8.20M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $5.41M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $3.75M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $2.70M 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $2.82M 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $2.42M 10-K · filed 2024-02-29 | $2.02M 10-K · filed 2023-03-01 |
| 2022-09-30 | $4.02M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $2.81M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $1.54M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $800.00K 10-K · filed 2023-03-01 | $2.07M 10-K · filed 2022-03-01 |
| 2021-09-30 | $754.00K 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $341.00K 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $229.00K 10-Q · filed 2021-05-03 | |
| 2020-12-31 | $180.00K 10-K · filed 2022-03-01 | |
| 2020-09-30 | $131.00K 10-Q · filed 2020-11-02 | |
| 2020-06-30 | $160.00K 10-Q · filed 2020-08-03 | |
| 2020-03-31 | $147.00K 10-Q · filed 2020-05-04 | |
| 2019-12-31 | $377.00K 10-K · filed 2021-03-01 | |
| 2019-09-30 | $112.00K 10-Q · filed 2019-11-01 | |
| 2019-06-30 | $242.00K 10-Q · filed 2019-07-29 | |
| 2019-03-31 | $1.05M 10-Q · filed 2019-05-03 | |
| 2018-12-31 | $60.00K 10-K · filed 2020-03-02 | |
| 2018-09-30 | $45.00K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $30.00K 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $13.00K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $18.00K 10-K · filed 2019-03-08 | |
| 2017-09-30 | $107.00K 10-Q · filed 2017-11-14 | |
| 2016-12-31 | $80.00K 8-K · filed 2018-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |